01-03-2018 | Letter to the Editor
Successful IVIG treatment without discontinuation of TNF-α blocker in Guillain-Barre syndrome induced by adalimumab in patient with Crohn’s disease
Published in: Neurological Sciences | Issue 3/2018
Login to get access